Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Loh

Showing results (11-20 of 372) with videos related to

Pageof 38
Sort By:
FEBS Letters|September 26, 1988
The effect of pepstatin A, an inhibitor of the pro-opiomelanocortin (POMC)-converting enzyme, on POMC processing in mouse intermediate pituitaryY P Loh
The Journal of the Indiana State Medical Association|October 1, 1978
Legionnaire's disease: a case report with review of literatureW P Loh
Biochemical Pharmacology|September 1, 1992
Molecular mechanisms of beta-endorphin biosynthesisY P Loh
The Journal of Biological Chemistry|September 15, 1986
Kinetic studies on the processing of human beta-lipotropin by bovine pituitary intermediate lobe pro-opiomelanocortin-converting enzymeY P Loh
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1979
Immunological evidence for two common precursors to corticotropins, endorphins, and melanotropin in the neurointermediate lobe of the toad pituitaryY P Loh
The Journal of the Indiana State Medical Association|December 1, 1972
Three-minute electrophoresis for rapid identification of hemoglobin SW P Loh
Fortschritte Der Kieferorthopadie|October 1, 1986
[Expansion of the upper dental arch of patients with cheilognathopalatoschisis]I Janson, P Loh
European Heart Journal|January 3, 2001
'Slow pathway' ablation in patients with atrioventricular nodal reentrant tachycardia: do we understand what we are doing?P Loh, G Breithardt
Life Sciences|December 27, 1982
Processing of normal and non-glycosylated forms of toad pro-opiocortin by rat intermediate (pituitary) lobe pro-opiocortin converting enzyme activityY P Loh, H Gainer
JACC. Cardiovascular Interventions|October 20, 2012
Paclitaxel drug-coated balloons: a review of current status and emerging applications in native coronary artery de novo lesionsJoshua P Loh, Ron Waksman
Pageof 38

Showing results (11-20 of 372) with videos related to

Sort By:
Pageof 38
FEBS Letters|September 26, 1988
The effect of pepstatin A, an inhibitor of the pro-opiomelanocortin (POMC)-converting enzyme, on POMC processing in mouse intermediate pituitaryY P Loh
The Journal of the Indiana State Medical Association|October 1, 1978
Legionnaire's disease: a case report with review of literatureW P Loh
Biochemical Pharmacology|September 1, 1992
Molecular mechanisms of beta-endorphin biosynthesisY P Loh
The Journal of Biological Chemistry|September 15, 1986
Kinetic studies on the processing of human beta-lipotropin by bovine pituitary intermediate lobe pro-opiomelanocortin-converting enzymeY P Loh
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1979
Immunological evidence for two common precursors to corticotropins, endorphins, and melanotropin in the neurointermediate lobe of the toad pituitaryY P Loh
The Journal of the Indiana State Medical Association|December 1, 1972
Three-minute electrophoresis for rapid identification of hemoglobin SW P Loh
Fortschritte Der Kieferorthopadie|October 1, 1986
[Expansion of the upper dental arch of patients with cheilognathopalatoschisis]I Janson, P Loh
European Heart Journal|January 3, 2001
'Slow pathway' ablation in patients with atrioventricular nodal reentrant tachycardia: do we understand what we are doing?P Loh, G Breithardt
Life Sciences|December 27, 1982
Processing of normal and non-glycosylated forms of toad pro-opiocortin by rat intermediate (pituitary) lobe pro-opiocortin converting enzyme activityY P Loh, H Gainer
JACC. Cardiovascular Interventions|October 20, 2012
Paclitaxel drug-coated balloons: a review of current status and emerging applications in native coronary artery de novo lesionsJoshua P Loh, Ron Waksman
Pageof 38